Cidara Therapeutics, Inc. (CDTX)
219.98
-0.31
(-0.14%)
USD |
NASDAQ |
Dec 10, 14:11
Cidara Therapeutics Research and Development Expense (TTM): 131.82M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Merck & Co., Inc. | 14.26B |
| Bristol Myers Squibb Co. | 9.719B |
| Johnson & Johnson | 15.77B |
| Mersana Therapeutics, Inc. | 68.92M |
| Pfizer Inc. | 10.13B |